Skip to main content
. 2018 Nov 1;10(1):e2018060. doi: 10.4084/MJHID.2018.060

Table 4.

KIR genes and Viral Markers.

KIR GENES n (%) HBeAg− HBeAg+ crude OR (95%CI) crude P value

Inhibitors
KIR2DL1

25 (27.5) 5 (26.3) Ref.

+ 66 (72.5) 14 (73.7) 1.06 (0.35–3.25) 0.918

KIR2DL2

53 (58.2) 10 (52.6) Ref.

+ 38 (41.8) 9(47.4) 1.26 (0.47–3.39) 0.653

KIR2DL3

30 (33) 5 (26.3) Ref.

+ 61 (67) 14 (73.7) 1.38 (0.45–4.18) 0.572

KIR2DL4

30 (33) 3 (15.8) Ref.

+ 61 (67) 16(84.2) 2.62 (0.71–9.7) 0.148

KIR2DL5A

58(63.7) 12(63.2) Ref.

+ 33(36.3) 7(36.8) 1.03 (0.37–2.86) 0.962

KIR2DL5B

49(53.8) 12(63.2) Ref.

+ 49 (46.2) 7(36.8) 0.68 (0.25,1.89) 0.459

KIR3DL1

32(35.2) 4(21.1) Ref.

+ 59(64.8) 15 (78.9) 2.03 (0.62–6.64) 0.24

KIR3DL2

31(34.1) 2(10.5) Ref.

+ 60(65.9) 17 (89.5) 4.39 (0.95–20.24) 0.058

KIR3DL3

28(30.8) 1(5.3) Ref.

+ 63(60.2) 18(94.7) 8 (1.02,62.91) 0.048

Activators
KIR2DS1

72(79.1) 16 (82.4) Ref.

+ 19(20.9) 3 (15.8) 0.71 (0.19–2.69) 0.615

KIR2DS2

57 (62.6) 8(42.1) Ref.

+ 34 (37.4) 11(57.9) 2.31 (0.84–6.3) 0.103

KIR2DS3

75 (82.4) 17 (89.5) Ref.

+ 16 (17.6) 2(10.5) 0.55 (0.12–2.63) 0.455

KIR2DS4

39 (42.9) 4 (21.4) Ref.

+ 52 (57.1) 15(78.9) 2.81 (0.87–9.14) 0.085

KIR2DS5

53 (58.2) 13(68.4) Ref.

+ 38(41.8) 6(31.6) 0.64 (0.22–1.85) 0.412

KIR3DS1

80 (87.9) 18 (94.7) Ref.

+ 11 (12.1) 1 (5.3) 0.4 (0.05–3.33) 0.4

Pseudogene
KIR2P1

44(48.4) 7(36.8) Ref.

+ 47(51.6) 12(63.2) 1.6 (0.58–4.45) 0.363